Urinary podocyte excretion as a marker for preeclampsia

被引:152
作者
Garovic, Vesna D.
Wagner, Steven J.
Turner, Stephen T.
Rosenthal, David W.
Watson, William J.
Brost, Brian C.
Rose, Carl H.
Gavrilova, Larisa
Craigo, Paula
Bailey, Kent R.
Achenbach, Johannes
Schiffer, Mario
Grande, Joseph P.
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[2] Mayo Clin, Div Obstet & Gynecol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Anesthesia, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Biostat, Rochester, MN 55905 USA
[5] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany
关键词
podocyturia; podocyte; preeclampsia;
D O I
10.1016/j.ajog.2007.02.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The objective of this study was to examine whether podocyturia, which is the urinary excretion of viable podocytes ( glomerular epithelial cells), is present in urinary sediments of patients with preeclampsia. We also aimed to compare the test characteristics of podocyturia to those angiogenic factors that have been shown to play an important role in the pathogenesis of preeclampsia (s-Flt-1, PlGF, and endoglin). STUDY DESIGN: Serum angiogenic factors were measured in 44 patients with preeclampsia and 23 normotensive control patients. In a patient subset (15 cases and 16 control patients), urinary proteinuria were identified and quantified on the basis of their expressions of podocyte-specific proteins. RESULTS: Urinary podocyte excretion occurred in all patients with preeclampsia. The positive predictive value for the diagnosis of preeclampsia was greater for podocyturia than for any of the measured angiogenic factors. CONCLUSION: Podocyturia is a highly sensitive and specific marker for preeclampsia. It may contribute to the development of proteinuria in preeclampsia.
引用
收藏
页码:320.e1 / 320.e7
页数:7
相关论文
共 18 条
[1]   Evidence supporting a rote for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia -: Young Investigator Award [J].
Chaiworapongsa, T ;
Romero, R ;
Espinoza, J ;
Bujoid, E ;
Kim, YM ;
Goçalves, LF ;
Gomez, R ;
Edwin, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (06) :1541-1547
[2]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845
[3]  
GAROVIC VD, 2007, NEPHROL DIAL TRANSPL
[4]  
Jones SL, 1998, HEMATOPATHOL MOL HEM, V11, P147
[5]   Molecular cloning and characterization of human podocalyxin-like protein - Orthologous relationship to rabbit PCLP1 and rat podocalyxin [J].
Kershaw, DB ;
Beck, SG ;
Wharram, BL ;
Wiggins, JE ;
Goyal, M ;
Thomas, PE ;
Wiggins, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) :15708-15714
[6]  
KIHARA I, 1997, KIDNEY INT S63, V52, pS171
[7]  
Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197
[8]   Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [J].
Levine, Richard J. ;
Lam, Chun ;
Qian, Cong ;
Yu, Kai F. ;
Maynard, Sharon E. ;
Sachs, Benjamin P. ;
Sibai, Baha M. ;
Epstein, Franklin H. ;
Romero, Roberto ;
Thadhani, Ravi ;
Karumanchi, S. Ananth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) :992-1005
[9]   Urinary placental growth factor and risk of preeclampsia [J].
Levine, RJ ;
Thadhani, R ;
Qian, C ;
Lam, C ;
Lim, KH ;
Yu, KF ;
Blink, AL ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (01) :77-85
[10]   Circulating angiogenic factors and the risk of preeclampsia [J].
Levine, RJ ;
Maynard, SE ;
Qian, C ;
Lim, KH ;
England, LJ ;
Yu, KF ;
Schisterman, EF ;
Thadhani, R ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :672-683